Purple Biotech (PPBT) Retained Earnings (2014 - 2026)
Purple Biotech (PPBT) reported Retained Earnings of -$171.2 million for Q1 2026, little changed on a QoQ basis from -$171.1 million in Q4 2025.
Purple Biotech (PPBT) has 11 years of Retained Earnings data on file, last reported at -$171.2 million in Q1 2026.
- Quarterly Retained Earnings changed N/A year-over-year to -$171.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$171.2 million (changed N/A YoY) and the FY2025 annual result came in at -$171.1 million, down 18.24% from the prior year.
- Retained Earnings held at -$171.2 million in Q1 2026 per PPBT's latest filing, from -$171.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$6000.0 in Q4 2022 and bottomed at -$171.2 million in Q1 2026.
- The 5-year median for Retained Earnings is -$144.7 million (2024), against an average of -$124.9 million.
- The widest annual swing landed in 2022, when Retained Earnings jumped 99.99%; it then tumbled 2290783.33% in 2023.
- Tracing PPBT's Retained Earnings over 5 years: stood at -$6000.0 in 2022, then plunged by 2290783.33% to -$137.5 million in 2023, then declined by 5.27% to -$144.7 million in 2024, then decreased by 18.24% to -$171.1 million in 2025, then declined by 0.05% to -$171.2 million in 2026.
- Per Business Quant, the three latest PPBT Retained Earnings figures stand at -$171.2 million (Q1 2026), -$171.1 million (Q4 2025), and -$144.7 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | -171.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -171.17 Mn |
| Dec 31, 2025 | -171.08 Mn |
| Sep 30, 2025 | -147.53 Mn |
| Jun 30, 2025 | -146.23 Mn |
| Mar 31, 2025 | -145.15 Mn |
| Dec 31, 2024 | -144.69 Mn |
| Sep 30, 2024 | -144.28 Mn |
| Jun 30, 2024 | -143.62 Mn |
| Mar 31, 2024 | -141.22 Mn |
| Dec 31, 2023 | -137.45 Mn |
| Sep 30, 2023 | -132.63 Mn |
| Jun 30, 2023 | -127.59 Mn |
| Mar 31, 2023 | -122.45 Mn |
| Dec 31, 2022 | -117.57 Mn |
| Sep 30, 2022 | -111.56 Mn |
| Jun 30, 2022 | -106.74 Mn |
| Mar 31, 2022 | -103.20 Mn |
| Dec 31, 2021 | -95.91 Mn |
| Sep 30, 2021 | -90.83 Mn |
| Jun 30, 2021 | -87.70 Mn |
| Mar 31, 2021 | -84.07 Mn |
| Dec 31, 2020 | -77.52 Mn |
| Jun 30, 2020 | -77.30 Mn |
| Dec 31, 2019 | -49.52 Mn |
| Jun 30, 2019 | -46.25 Mn |
| Dec 31, 2018 | -43.67 Mn |
| Jun 30, 2018 | -43.33 Mn |
| Dec 31, 2017 | -38.47 Mn |
| Jun 30, 2017 | -32.02 Mn |
| Dec 31, 2016 | -26.20 Mn |
| Jun 30, 2016 | -17.09 Mn |
| Dec 31, 2015 | -14.05 Mn |
| Sep 30, 2015 | -12.79 Mn |
| Dec 31, 2014 | -9.85 Mn |
| Sep 30, 2014 | -9.05 Mn |